Rating History for Xenon Pharmaceuticals (XENE) by Guggenheim
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 10/5/2026 | Delma Caiati | New Coverage | Buy (N/A) |
73.00 (N/A) |
38.02 (33.49) |
-11.91% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 10/5/2026 | Delma Caiati | New Coverage | Buy (N/A) |
73.00 (N/A) |
38.02 (33.49) |
-11.91% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||